Discover the iOS 19 bold redesign with transparency, 3D effects, and rounded icons. Apple’s most stunning update since iOS 7 ...

Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Four renowned individuals with contributions to science, technology, the arts, and design will receive honorary degrees from ...

The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.

Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...